Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with Fujifilm as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback